EcoDrugPlus

Adrenoceptor Alpha 1aa

Ensembl ID : ENSDARG00000028725
Gene Symbol: ADRA1AA
9 Enzyme and pathways 5 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1ba

Ensembl ID : ENSDARG00000011317
Gene Symbol: ADRA1BA
9 Enzyme and pathways 5 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSDARG00000041173
Gene Symbol: ADRA1BB
5 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSDARG00000024101
Gene Symbol: ADRA1D
9 Enzyme and pathways 5 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSDARG00000102096
Gene Symbol: ADRA2B
13 Enzyme and pathways 5 Cross references
211 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSDARG00000069669
Gene Symbol: ADRA2C
17 Enzyme and pathways 5 Cross references
162 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSDARG00000007490
Gene Symbol: ADRB1
8 Enzyme and pathways 5 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSDARG00000088124
Gene Symbol: ADRB2A
5 Cross references
196 Possible Orthologues:

Adrenoceptor Beta 2, Surface B

Ensembl ID : ENSDARG00000054510
Gene Symbol: ADRB2B
16 Enzyme and pathways 5 Cross references
150 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSDARG00000053646
Gene Symbol: ADRB3A
8 Enzyme and pathways 5 Cross references
197 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSDARG00000052919
Gene Symbol: ADRB3B
5 Cross references
146 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSDARG00000006215
Gene Symbol: AKR1B1.1
17 Enzyme and pathways 5 Cross references
350 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).